Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management
- 20 June 2013
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 88 (8), 703-711
- https://doi.org/10.1002/ajh.23472
Abstract
No abstract availableThis publication has 97 references indexed in Scilit:
- VWF, WM, and angiogenesis: is there a link?Blood, 2012
- Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenström macroglobulinemiaBlood, 2012
- Temporal and geographic variations of Waldenstrom macroglobulinemia incidenceCancer, 2011
- Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patientsAmerican Journal of Hematology, 2011
- Waldenström's Macroglobulinemia: Hyperviscosity Syndrome and CryoglobulinemiaClinical Lymphoma Myeloma and Leukemia, 2009
- Neurological manifestations of Waldenström macroglobulinemiaNature Clinical Practice Neurology, 2008
- Waldenström's macroglobulinemiaBest Practice & Research Clinical Haematology, 2005
- Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: A two-institution studySeminars in Oncology, 2003
- Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003